Oral clinical nutrition supplement includes oral intake products for dietary foods with the special medical purposes. This Oral clinical nutrition supplement has nutritional, functional, and economic benefits for patients with poor food intake, low appetite, and for the malnutrition. Main function of the oral clinical nutrition supplement is increasing the protein and energy intake for the patients as well as it is responsible for the stimulation of appetite in the particular patient group.
Global Oral Clinical Nutrition Supplement Market Drivers
New product launches is expected to drive the global oral clinical nutrition supplement market growth. For instance, in April 2018, Abbott launched its new protein Ensure Max, which contains 150-calorie beverage with 30 grams of protein and nine essential amino acids. It is also contains 1 gram of sugar and 22 vitamins and minerals including calcium, Vitamin C, Vitamin D, and Vitamin E.
Furthermore, in April 2019, PRO-DIP launched its oral nutritional supplement (revolutionary pouch), which delivers the nutrients and energy in a small, semi-permeable sachets. These pouches are filled with fruit punched flavored powder, which contains vitamin B, vitamin C, caffeine, Beta-alanine, taurine. These pouches used as an alternative to smokeless tobacco. Hence, production of revolutionary pouches may drive the global oral clinical nutrition supplement market growth.
Global Oral Clinical Nutrition Supplement Market Restraints
Product recall is the major challenge for the oral clinical nutrition supplement market, which is expected to hamper growth of the global oral clinical nutrition market. For instance, in April 2018, all batches of Now Foods vitamin A supplements were withdrawn by the Power Body Nutrition. The main reason is longer consumption of this product causes the liver and bone toxicity and in pregnant women it has risk of birth defects.
Global Oral Clinical Nutrition Supplement Market Regional Analysis
On the basis of region, the global oral clinical nutrition supplement market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global oral nutrition supplement market, owing to increase in the collaboration activities by the key players over the forecast period. For instance, in January 2018, Filament BioSolutions, Inc. collaborated with the University of Ottawa and Children’s Hospital of Eastern Ontario (CHEO) for the study and development of the clinical applications of microbiome-based precision nutrition in inflammatory bowel disease (IBD).
Furthermore, Asia Pacific is also projected to witness significant growth in the global oral clinical nutrition supplement market, owing to new product launches during the forecast period. For instance, in February 2019, Matok V’Kal Company launched its new stamina boosting oral spray (Fit4style) in Asia Pacific region. Fit4style is with the mint flavor and contains only 6 calories and zero caffeine. Hence, it is expected to help maintain stamina.
Key players operating in the oral clinical nutrition supplement market are Baxter International Inc., Pharmavite LLC, Bayer AG, Church & Dwight Co. Inc., Fresenius Kabi AG, Mead Johnson & Company, LLC, Otsuka Pharmaceutical Europe Ltd, Abbott Laboratories, Danone Nutricia, Victus, Inc., Cambrooke Therapeutics, Inc., GlaxoSmithKline plc, and Nestlé S.A.
Global Oral Clinical Nutrition Supplement Market Taxonomy
By Product Type:
By Dosage Form:
By Age Group:
- General Well-being
- Renal Disorders
- Hepatic Disorders
- Oncology Nutrition
- IBD & GI Tract Disorders
- Neurological Disorders
- Respiratory Disorders
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Asia Pacific
- Latin America
- Middle East